Biomapas

Executive Summary

Biomapas, founded in 2005 and headquartered in Vilnius, is a pan-European pharma services provider offering specialized Pharmacovigilance, Medical Information, Clinical Development, and Regulatory Affairs services. With a global reach and a strong Baltic presence, the company supports pharmaceutical clients in ensuring drug safety, compliance, and market access. As a private firm with no disclosed funding or valuation, Biomapas has a stable operational history but limited public growth indicators. Its established service portfolio positions it well in the competitive CRO landscape, though near-term catalysts are unclear without recent pipeline announcements or partnerships.

Upcoming Catalysts (preview)

• Q4 2026Geographic expansion of pharmacovigilance services into new European markets70% success
• Q1 2027Strategic partnership with a mid-sized biotech for clinical development projects50% success
• Q2 2026Achievement of ISO or other regulatory certification to enhance service credibility80% success